Published in J Nutr Biochem on August 01, 2004
Oleuropein in olive and its pharmacological effects. Sci Pharm (2010) 1.53
Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients (2013) 1.14
Effects of the olive-derived polyphenol oleuropein on human health. Int J Mol Sci (2014) 0.98
Cardioprotective and neuroprotective roles of oleuropein in olive. Saudi Pharm J (2010) 0.92
Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases. J Transl Med (2014) 0.90
Dietary oxidative stress and antioxidant defense with an emphasis on plant extract administration. Cell Stress Chaperones (2011) 0.85
Prolonged Oral Administration of Oleuropein Might Protect Heart against Aconitine-induced Arrhythmia. Iran J Pharm Res (2012) 0.81
The antioxidant effects of a polyphenol-rich grape pomace extract in vitro do not correspond in vivo using exercise as an oxidant stimulus. Oxid Med Cell Longev (2012) 0.81
The effect of olive leaf extract in decreasing the expression of two pro-inflammatory cytokines in patients receiving chemotherapy for cancer. A randomized clinical trial. Saudi Dent J (2013) 0.80
Computer-aided discovery of biological activity spectra for anti-aging and anti-cancer olive oil oleuropeins. Aging (Albany NY) (2014) 0.79
Prophylactic and Therapeutic Effects of Oleuropein on Reperfusion-Induced Arrhythmia in Anesthetized Rat. Iran Biomed J (2015) 0.78
Oleuropein offers cardioprotection in rats with simultaneous type 2 diabetes and renal hypertension. Indian J Pharmacol (2014) 0.77
Nutraceutical Properties of Olive Oil Polyphenols. An Itinerary from Cultured Cells through Animal Models to Humans. Int J Mol Sci (2016) 0.77
The anti-infarct, antistunning and antiarrhythmic effects of oleuropein in isolated rat heart. EXCLI J (2012) 0.76
Diet-induced increase in plasma oxidized LDL promotes early fibrosis in a renal porcine auto-transplantation model. J Transl Med (2014) 0.75
Effect of oleuropein on myocardial dysfunction and oxidative stress induced by ischemic-reperfusion injury in isolated rat heart. J Ayurveda Integr Med (2016) 0.75
Encapsulation of Olive Leaves Extracts in Biodegradable PLA Nanoparticles for Use in Cosmetic Formulation. Bioengineering (Basel) (2017) 0.75
Oleuropein attenuates the progression of heart failure in rats by antioxidant and antiinflammatory effects. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
Oleuropein Protects Cardiomyocyte against Apoptosis via Activating the Reperfusion Injury Salvage Kinase Pathway In Vitro. Evid Based Complement Alternat Med (2017) 0.75
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med (2006) 5.07
Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. J Am Coll Cardiol (2010) 2.56
Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation (2003) 2.41
Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet (2003) 2.39
C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. Int J Cardiol (2011) 2.14
Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol (2003) 1.89
Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis. Int J Cardiol (2008) 1.76
Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion. Cardiovasc Res (2006) 1.75
Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. Hepatology (2005) 1.74
Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats. Circ Res (2002) 1.67
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res (2005) 1.67
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. J Am Coll Cardiol (2008) 1.65
Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. J Hypertens (2009) 1.63
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. Eur Heart J (2007) 1.62
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res (2005) 1.57
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. JACC Cardiovasc Interv (2009) 1.56
Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload. Hypertension (2009) 1.53
Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy. J Am Coll Cardiol (2002) 1.48
Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation (2003) 1.48
Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. Int J Cardiol (2007) 1.46
Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited? Intern Emerg Med (2010) 1.45
The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells: another piece in the adipokines puzzle. Thromb Res (2012) 1.45
Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials. Catheter Cardiovasc Interv (2009) 1.43
[Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure]. G Ital Cardiol (Rome) (2010) 1.40
Relationship between contractile reserve, Tl-201 uptake, and collateral angiographic circulation in collateral-dependent myocardium: implications regarding the evaluation of myocardial viability. J Nucl Cardiol (2003) 1.39
Rapid ultrasound score as an indicator of atherosclerosis' clinical manifestations in a population of hypertensives: the interrelationship between flow-mediated dilatation of brachial artery, carotid intima thickness, renal resistive index and retina resistive index of central artery. Anadolu Kardiyol Derg (2013) 1.38
[Assessment of quality of life in patients with peripheral arterial disease: a problem left ahead]. G Ital Cardiol (Rome) (2009) 1.37
p27Kip1 metabolism: a fascinating labyrinth. Cell Cycle (2007) 1.34
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster. Blood (2005) 1.26
[European National Society cardiovascular journals. Background, rationale and mission statement of the "editors' club"]. Rev Esp Cardiol (2008) 1.26
Resveratrol: from basic science to the clinic. Cell Cycle (2007) 1.23
Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? Atherosclerosis (2008) 1.21
p21Cip1 gene expression is modulated by Egr1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect. J Biol Chem (2003) 1.19
Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation (2005) 1.15
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. BMC Cardiovasc Disord (2010) 1.12
AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stress. Cardiovasc Res (2010) 1.09
Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol (2004) 1.08
Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation (2006) 1.07
Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation. Circulation (2002) 1.06
Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death. Eur J Haematol (2011) 1.06
Increased heterogenity of ventricular repolarization in obese nonhypertensive children. Pacing Clin Electrophysiol (2010) 1.04
Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clin Nutr (2008) 1.03
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. J Investig Med (2011) 1.02
Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy. J Nucl Cardiol (2007) 1.02
The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function. Blood (2005) 1.02
EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy. Basic Res Cardiol (2011) 1.02
Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Nephrol Dial Transplant (2010) 1.01
Protein isoaspartate methyltransferase prevents apoptosis induced by oxidative stress in endothelial cells: role of Bcl-Xl deamidation and methylation. PLoS One (2008) 1.00
Retinoic acid induces p27Kip1 nuclear accumulation by modulating its phosphorylation. Cancer Res (2006) 0.99
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study. Europace (2010) 0.98
Rat carotid artery dilation by PTCA balloon catheter induces neointima formation in presence of IEL rupture. Am J Physiol Heart Circ Physiol (2002) 0.98
Increased dispersion of ventricular repolarization in Emery Dreifuss muscular dystrophy patients. Med Sci Monit (2012) 0.98
Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis (2004) 0.97
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents. FASEB J (2009) 0.95
Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease. Am J Cardiol (2005) 0.95
Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach? Curr Vasc Pharmacol (2010) 0.94
Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury. Am J Physiol Heart Circ Physiol (2004) 0.94
Resveratrol: from basic studies to bedside. Cancer Treat Res (2014) 0.94
Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease? Intern Emerg Med (2008) 0.94
Thoracic aortic emergencies: impact of endovascular surgery. Ann Thorac Surg (2004) 0.93
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. Europace (2011) 0.93
Myocardial texture in hypertrophic cardiomyopathy. J Am Soc Echocardiogr (2007) 0.93
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. Eur Heart J (2010) 0.93
Early electrocardiographic evaluation of atrial fibrillation risk in beta-thalassemia major patients. Int J Hematol (2011) 0.93
Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. Eur J Cardiovasc Prev Rehabil (2008) 0.92
Myocardial strain analysis in a doxorubicin-induced cardiomyopathy model. Ultrasound Med Biol (2007) 0.92
Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology. Curr Vasc Pharmacol (2011) 0.92
Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep (2014) 0.91
Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity. J Vasc Surg (2006) 0.90
Leukocyte count in peripheral arterial disease: A simple, reliable, inexpensive approach to cardiovascular risk prediction. Atherosclerosis (2009) 0.90
Effect of reddening-ripening on the antioxidant activity of polyphenol extracts from cv. 'Annurca' apple fruits. J Agric Food Chem (2007) 0.90
Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes. Circulation (2003) 0.89
Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J (2007) 0.89
Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion. Catheter Cardiovasc Interv (2010) 0.89
Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation (2004) 0.88
In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats. Nephrol Dial Transplant (2007) 0.88
Protein methylation as a marker of aspartate damage in glucose-6-phosphate dehydrogenase-deficient erythrocytes: role of oxidative stress. Eur J Biochem (2002) 0.88
Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation. Mol Cell Biochem (2003) 0.88
The first agmatine/cadaverine aminopropyl transferase: biochemical and structural characterization of an enzyme involved in polyamine biosynthesis in the hyperthermophilic archaeon Pyrococcus furiosus. J Bacteriol (2007) 0.88
Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr (2009) 0.87
Leptin stimulated C-reactive protein production by human coronary artery endothelial cells. J Vasc Res (2009) 0.87
Hydroxytyrosol, a natural antioxidant from olive oil, prevents protein damage induced by long-wave ultraviolet radiation in melanoma cells. Free Radic Biol Med (2005) 0.87
Free radicals and antioxidants in cardiovascular diseases. Expert Rev Cardiovasc Ther (2005) 0.87
Targeted inhibition of phosphoinositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure. Vascul Pharmacol (2006) 0.86
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. Pacing Clin Electrophysiol (2012) 0.86
Cellular adhesion molecules and peripheral arterial disease. Vasc Med (2006) 0.86
Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification. Thromb Haemost (2005) 0.86